BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose vaccine candidate, following phase 1/2 studies that demonstrated safety and immunogenicity. “As COVID-19 continues to impact the daily lives of people around the world, our goal remains the same – leveraging the global reach and scientific innovation […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase 1 study evaluating dubermatinib (TP-0903) in patients with advanced solid tumors. “These preliminary data presented at ESMO 2020 are encouraging as we learn more about how dubermatinib may inhibit the AXL kinase protein and sensitize cancer cells […]
During a campaign event yesterday in Charlotte, North Carolina, President Trump signed an executive order on a range of health issues, including protecting people with pre-existing medical conditions, lowering prescription drug costs, increasing consumer choice, and providing greater transparency. The order also directs HHS Secretary Alex Azar to work with Congress to pass legislation to […]
RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. This means that KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with […]
BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and grant programs managed by the Governor’s Office of Economic Development. Visit business.utah.gov/coronavirus to learn more. Coronavirus Prevention Messaging Grants Grants of up to $50,000, $75,000 or $250,000 for social media, targeted audience and mass media campaigns, respectively, […]
The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year. The plan would prioritze vaccines for healthcare workers, essential employees, and high-risk indiividuals. From there, distribution would be expanded to the broader population. The plan includes two documents: documents: A strategic distribution overview along with an interim […]
TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of Public Health has changed direction and contracted with a Los Angeles laboratory, Fulgent Genetics, to process COVID-19 testing for Utahns under the state’s coronavirus testing initiative. The test, which has received EUA from the FDA, will be […]
On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]
Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]
President Trump issued a new “Most-Favored-Nations” (MFN) executive order on September 13 that links U.S.-paid Medicare drug prices to those paid by other foreign countries. BIO President and CEO, Dr. Michelle McMurry-Heath, called the President’s action a “reckless scheme” that would hurt vulnerable seniors. The new order includes both Medicare Part B and Part D […]
In a double header of good news, Salt Lake City -based Recursion announced on Wednesday that the company has entered into a strategic collaboration agreement with Bayer to discover and develop new treatments for fibrotic diseases of the lung, kidney, heart and more. The agreement leverages Recursion’s AI drug discovery platform and Bayer’s small molecule […]